Showing 3,161 - 3,180 results of 3,305 for search '"labelling"', query time: 0.07s Refine Results
  1. 3161

    Combination of Compound Kushen injection with first-line treatment versus first-line treatment alone for advanced colorectal cancer: a study protocol for a multicenter, openlabel,... by Jingyuan Wu, Yuansha Ge, Guanghui Zhu, Ruike Gao, Xiaoyu Zhu, Ying Zhang, Jie Li

    Published 2024-12-01
    “…Methods This is a multicenter, randomized, open-label controlled clinical trial in which 320 patients with advanced CRC will be randomly assigned to the treatment group or the control group in a 1:1 ratio. …”
    Get full text
    Article
  2. 3162

    Identification of serum metabolite biomarkers in premature infants with bronchopulmonary dysplasia: protocol for a multicentre prospective observational cohort study by Ping Zhou, Jun Chen, Ying Liu, Cheng Chen, Xin Guo, Zhangbin Yu, Jiebo Liu, Yanping Guo, Dan Dan Rao, Shengnan He, Xudong Yan, Wanxiang He, Songzhou Xu, Ruolin Zhang

    Published 2025-01-01
    “…This will provide strong support for the early prediction of BPD and targeted interventions in future research.Methods and analysis This is a prospective, multicentre, open-label, observational cohort study spanning 3 years. …”
    Get full text
    Article
  3. 3163
  4. 3164

    Phase I study of intratumoral administration of CV8102 in patients with advanced melanoma, squamous cell carcinoma of the skin, squamous cell carcinoma of the head and neck, or ade... by Lucie Heinzerling, Michael Fluck, Caroline Robert, Celeste Lebbe, Erika Richtig, Sven D Koch, Ulrike Gnad-Vogt, Tobias Seibel, Thomas Eigentler, Juan Martin-Liberal, Sebastian Ochsenreither, Peter Mohr, Patrick Terheyden, Carsten Weishaupt, Michael Erdmann, Lukas Koch, Ainara Soria, Igor Samoylenko, Jürgen Krauß, Peter Brossart, Franz Georg Bauernfeind, Marina Gonzalez, Peter Wengenmayer, Ioannis Thomas, Artem Poltoratskiy, Marina Sekacheva, Beate Schmitt-Bormann, Gianluca Quintini, Martin Falk, Paula Codó, Arjun Oberoi, Jana Hess, Yulia Semiletova, Casilda Llacer Perez, Oliver Schönborn-Kellenberger

    Published 2025-02-01
    “…We investigated intratumoral (IT) administration of CV8102 in patients with anti-programmed cell death protein-1 (PD-1) therapy-naïve or anti-PD-1 therapy-refractory cutaneous melanoma (cMEL) and in patients with advanced cutaneous squamous cell carcinoma, head and neck squamous cell carcinoma and adenoid cystic carcinoma.Methods This open-label, cohort-based, phase I dose escalation study aimed to establish the maximum tolerated dose (MTD), recommended dose (RD), safety and preliminary efficacy of CV8102 as monotherapy or in combination with a PD-1 inhibitor. …”
    Get full text
    Article
  5. 3165

    Low Incidence of Postoperative Respiratory Depression with Oliceridine Compared to Morphine: A Retrospective Chart Analysis by Sergio Bergese, Richard Berkowitz, Paul Rider, Martin Ladouceur, Suzanne Griffith, Alvaro Segura Vasi, Kristina Cochrane, Linda Wase, Mark A. Demitrack, Ashraf S. Habib

    Published 2020-01-01
    “…In randomized controlled studies in both hard and soft tissue models yielding surgical pain, oliceridine provided effective analgesia with a potential for an improved safety and tolerability profile at equianalgesic doses to morphine. The phase 3, open-label, single-arm, multicenter ATHENA trial demonstrated the safety, tolerability, and effectiveness of oliceridine in moderate to severe acute pain in a broad range of patients undergoing surgery or with painful medical conditions warranting use of an IV opioid. …”
    Get full text
    Article
  6. 3166

    Comparison of 1D and 3D volume measurement techniques in NF2-associated vestibular schwannoma monitoring by Isabel Gugel, Nuran Aboutaha, Bianca Pfluegler, Ulrike Ernemann, Martin Ulrich Schuhmann, Marcos Tatagiba, Florian Grimm

    Published 2025-01-01
    “…For this reason, they are not recommended for monitoring off-label therapy with Bevacizumab or for treatment decisions depending on a precise assessment of tumor volume and growth. …”
    Get full text
    Article
  7. 3167

    Harmful and Potentially Harmful Constituents Analysis of North American ENDS by Smith Cameron, Jamison Brian, Jongsma Candice, Carter Karen, Wang Jiaming, Bates Austin, Ullah Sifat, Cook David, Gene Gillman I.

    Published 2024-10-01
    “…The study consisted of 14 brands (seven closed pod-based, four open (refillable) pod-based, two cigalike, one disposable) and analyzed multiple e-liquid formulations per brand with varying labelled nicotine concentrations and flavors, equating to 35 unique tested ENDS. …”
    Get full text
    Article
  8. 3168
  9. 3169
  10. 3170
  11. 3171

    Evaluating the impact of faculty development programs at the workplace by using reflective critique writing technique by Sarah Amin, Shabana Ali Muhammad, Rahila Yasmeen

    Published 2025-01-01
    “…Participants experience of Reflective Critique writing was explored further in the qualitative part of the studies and results showed multiple themes including ongoing teaching skills, increased higher order thinking and making sense of experience. Participants labelled Reflective Critique as: The Game Changer. …”
    Get full text
    Article
  12. 3172
  13. 3173

    Identifying Organizational Factors and Components Influencing Customer Experience Management Maturity: A Meta-synthesis Approach by Payam Mardazad Navi, Kambiz Heidarzadeh Hanzaee, Seyyed Buik Mohammadi, Mohsen Khoon Siavash

    Published 2023-12-01
    “…Findings After analyzing the papers, several codes were extracted and labeled based on similarity and frequency of replication in 10 main themes, 26 concepts, and 116 open codes (with replication). …”
    Get full text
    Article
  14. 3174

    Effects of the Paediatric Regulation funding on the development of off-patent medicines in children by Lucia Ruggieri, Silvia Torretta, Viviana Giannuzzi, Alessandra Natale, Mariagrazia Felisi, Adriana Ceci, Adriana Ceci, Fedele Bonifazi

    Published 2025-01-01
    “…IntroductionIn paediatrics, medicines repurposing is a particularly advantageous approach, offering a route to address unmet medical needs and turn off-label use into evidence-based treatments for paediatric populations. …”
    Get full text
    Article
  15. 3175

    Budget Impact of Rivaroxaban for the Prevention of Thromboembolic Events after Hip or Knee Replacement in Spain by Xavier Granero Xiberta, Antonio Murcia, José Ricardo Troncoso Durán, Claudio Gómez Zubeldia, Aleix Llorac Moix, Ruth Graefenhain De Codes, Maria Giovana Ferrario, Luis Lizán

    Published 2016-01-01
    “…Data related to rate of thromboembolic events, major bleeding events and use of resources (local or general anesthesia and nurse care after surgery) were obtained from the Xarelto® for VTE Prophylaxis After Hip or Knee Arthroplasty (XAMOS) study, an international, non-interventional, observational, open-label study in unselected patients undergoing THR or TKR surgery in routine practice. …”
    Get full text
    Article
  16. 3176

    A deep learning model for assistive decision-making during robot-aided rehabilitation therapies based on therapists’ demonstrations by David Martínez-Pascual, José M. Catalán, Luís D. Lledó, Andrea Blanco-Ivorra, Nicolás García-Aracil

    Published 2025-01-01
    “…This assistance provided by the therapist was detected to label those trajectories that were assisted to train a Deep Learning model that learns from the therapist when to assist. …”
    Get full text
    Article
  17. 3177

    Inhibition of p70 Ribosomal S6K1 Protects the Myocardium against Ischemia/Reperfusion-Induced Necrosis through Downregulation of RIP3 by Hui Shang, Jinjin Shi, Jun Zhu, Yunfeng Guo, Xiaoyan Wang

    Published 2025-01-01
    “…Terminal deoxynucleotidyl transferase dUTP nick-end labeling (TUNEL) staining and propidium iodide (PI) staining were used to examine the apoptosis and necrosis of myocardial tissues. …”
    Get full text
    Article
  18. 3178

    The landscape of immunogenic cell death-related genes predicts the overall survival and immune infiltration status of non-small-cell lung carcinoma by Jian Zhang, Huiying Li, Xi Zhang, Yue Yang, Yue Sun

    Published 2025-01-01
    “…This was followed by univariate and multivariate Cox regression and LASSO regression analyses, we developed a prognostic risk model based on the TCGA cohort, which included 17 gene labels. The results of the external validation were then used to identify the appropriate genes for use in predicting the survival outcome of patients with this type of cancer. …”
    Get full text
    Article
  19. 3179

    Proteomic analysis of spinal dorsal horn in prior exercise protection against neuropathic pain by Binglin Chen, Jiabao Guo, Chan Gong, Chenchen Zhu, Yang Wu, Shengbo Wang, Yili Zheng, Haixia Lu

    Published 2025-01-01
    “…LC–MS/MS proteomic analysis based on the label-free approach was used to detect protein profiles, and volcano plots, Venn diagrams, and clustering heatmaps were used to identify differentially expressed proteins (DEPs). …”
    Get full text
    Article
  20. 3180

    ϵ-Confidence Approximately Correct (ϵ-CoAC) Learnability and Hyperparameter Selection in Linear Regression Modeling by Soosan Beheshti, Mahdi Shamsi

    Published 2025-01-01
    “…The practical uncertainty of the label samples in the training data set has a major effect in the generalization ability of the learned model. …”
    Get full text
    Article